Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
Tipo del documento
Publication year range
1.
Bull Exp Biol Med ; 172(2): 133-136, 2021 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-34853965

RESUMEN

We analyzed changes in activities of enzymes of phases I and II of xenobiotic biotransformation and parameters of NO metabolism in liver microsomes of rats with toxic CCl4-induced hepatitis after a 14-day course of sesquiterpene lactones from Artemisia leucodes (10 mg/kg). It was found that toxic hepatitis was associated with significant inhibition of NADPH-cytochrome c-reductase, benzo(a)pyrene hydroxylase, and NADPH-diaphorase, reduced cytochrome P-450 content, and enhanced induction of nitrate/nitrite reductase with accumulation of NO metabolites in the liver. Administration of sesquiterpene lactones stimulated activity of the studied components of the cytochrome P-450 system and promoted recovery of the NOergic system components; the effects were most pronounced in 7 and 14 days after treatment.


Asunto(s)
Enfermedad Hepática Inducida por Sustancias y Drogas/metabolismo , Lactonas/farmacología , Microsomas Hepáticos/metabolismo , Oxigenasas de Función Mixta/metabolismo , Óxido Nítrico/metabolismo , Animales , Animales no Consanguíneos , Enfermedad Hepática Inducida por Sustancias y Drogas/tratamiento farmacológico , Enfermedad Hepática Inducida por Sustancias y Drogas/patología , Sistema Enzimático del Citocromo P-450/metabolismo , Citoprotección/efectos de los fármacos , Lactonas/uso terapéutico , Hígado/efectos de los fármacos , Hígado/metabolismo , Masculino , Microsomas Hepáticos/efectos de los fármacos , Microsomas Hepáticos/enzimología , Fitoquímicos/farmacología , Ratas , Sesquiterpenos/farmacología , Sesquiterpenos/uso terapéutico
2.
Bull Exp Biol Med ; 170(1): 24-29, 2020 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-33222079

RESUMEN

Structural myocardial reorganization and changes in the blood lipid spectrum in rats were studied after administration of a single sublethal dose of doxorubicin (15 mg/kg) alone and in combination with atorvastatin (20 mg/kg/day over 7 days). It was established that doxorubicin induced the development of dyslipidemia in experimental animals (the concentrations of total cholesterol, triglycerides, and VLDL increased by 2.2, 2.0, and 1.96 times, respectively; the atherogenic coefficient increased by 3.4 times by day 7 of the experiment). In animals with experimental anthracycline cardiomyopathy treated with atorvastatin, the concentrations of the main components of the blood lipid spectrum increased less markedly. Atorvastatin alone induces moderate myocardial remodeling in comparison with more pronounced changes in the structural organization of the myocardium in rats treated with doxorubicin alone. Course treatment with atorvastatin under conditions of doxorubicin-induced cardiomyopathy reduced the severity of myocardial remodeling: the decrease in the volume density of cardiomyocytes and the increase in the volume density of the connective tissue were less pronounced in the dynamics of the experiment.


Asunto(s)
Antibióticos Antineoplásicos/efectos adversos , Anticolesterolemiantes/farmacología , Atorvastatina/farmacología , Cardiomiopatías/tratamiento farmacológico , Doxorrubicina/antagonistas & inhibidores , Dislipidemias/tratamiento farmacológico , Animales , Remodelación Atrial/efectos de los fármacos , Peso Corporal/efectos de los fármacos , Cardiomiopatías/sangre , Cardiomiopatías/inducido químicamente , Cardiomiopatías/patología , Colesterol/sangre , Doxorrubicina/efectos adversos , Dislipidemias/sangre , Dislipidemias/inducido químicamente , Dislipidemias/patología , Femenino , Lipoproteínas VLDL/sangre , Miocitos Cardíacos/efectos de los fármacos , Miocitos Cardíacos/metabolismo , Miocitos Cardíacos/patología , Tamaño de los Órganos/efectos de los fármacos , Ratas , Ratas Wistar , Triglicéridos/sangre
3.
Eksp Klin Farmakol ; 75(4): 26-9, 2012.
Artículo en Ruso | MEDLINE | ID: mdl-22702108

RESUMEN

The introduction of polyprenols isolated from fir (Abies) tree in male rats weighing 170 - 180 g with alcohol-induced hepatitis favored reduction in hepatocyte cytolysis and cholestasis and led to an improvement of the protein- and glycogen-synthesizing function of liver. A clear tendency to normalization of the maintenance of total lipids, triglycerides and phospholipids and the inhibition of lipid peroxidization processes in the damaged organ was observed. The introduction of Abies polyprenols also improved the process of bile secretion and its chemical composition.


Asunto(s)
Abies/química , Depresores del Sistema Nervioso Central/efectos adversos , Enfermedad Hepática Inducida por Sustancias y Drogas/tratamiento farmacológico , Etanol/efectos adversos , Silimarina/química , Terpenos/farmacología , Animales , Bilis/metabolismo , Depresores del Sistema Nervioso Central/farmacología , Enfermedad Hepática Inducida por Sustancias y Drogas/metabolismo , Etanol/farmacología , Glucógeno/biosíntesis , Hepatocitos/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Masculino , Biosíntesis de Proteínas/efectos de los fármacos , Ratas , Terpenos/química
4.
Biomed Khim ; 66(5): 357-371, 2020 Sep.
Artículo en Ruso | MEDLINE | ID: mdl-33140729

RESUMEN

The manifestation of the side cardiotoxic effect of anthracycline antibiotics limits their use in the treatment of malignant processes in some patients. The review analyzes the main causes of the susceptibility of cardiomyocytes to the damaging effect of anthracyclines, primarily associated with an increase in the processes of free radical oxidation. Currently, research is widely carried out to find ways to reduce anthracycline cardiotoxicity, in particular, the use of cardioprotective agents in the complex treatment of tumors. Hydroxymethylglutaryl coenzyme A reductase inhibitors (statins) have been shown to improve the function and metabolism of the cardiovascular system under various pathological impacts, therefore, it is proposed to use them to reduce cardiotoxic complications of chemotherapy. Statins exhibit direct (hypolipidemic) and pleiotropic effects due to the blockade of mevalonic acid synthesis and downward biochemical cascades that determine their cardioprotective properties. The main point of intersection of the pharmacological activity of anthracyclines and statins is the ability of both to regulate the functioning of small GTPase from the Rho family, and their effect in this regard is the opposite. The influence of statins on the modification and membrane dislocation of Rho proteins mediates the indirect antioxidant, anti-inflammatory, endothelioprotective, antiapoptotic effect. The mechanism of statin inhibition of doxorubicin blockade of the DNA-topoisomerase complex, which may be important in preventing cardiotoxic damage during chemotherapy, is discussed. At the same time, it should be noted that the use of statins can be accompanied by adverse side effects: a provocation of increased insulin resistance and glucose tolerance, which often causes them to be canceled in patients with impaired carbohydrate metabolism, so further studies are needed here. The review also analyzes data on the antitumor effect of statins, their ability to sensitize the tumor to treatment with cytostatic drug. It has been shown that the relationship between anthracycline antibiotics and statins is characterized not only by antagonism, but also in some cases by synergism. Despite some adverse effects, statins are one of the most promising cardio- and vasoprotectors for use in anthracycline cardiomyopathy.


Asunto(s)
Miocitos Cardíacos , Antraciclinas/efectos adversos , Antibacterianos , Cardiotoxicidad , Humanos , Inhibidores de Hidroximetilglutaril-CoA Reductasas/efectos adversos
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda